The Clorox Company (NYSE:CLX) Shares Sold by Mirabella Financial Services LLP

Mirabella Financial Services LLP lowered its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 69.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,675 shares of the company's stock after selling 6,115 shares during the period. Mirabella Financial Services LLP's holdings in Clorox were worth $434,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of the business. Norges Bank acquired a new stake in Clorox in the fourth quarter valued at approximately $259,041,000. FMR LLC increased its position in Clorox by 75.4% during the 4th quarter. FMR LLC now owns 1,361,758 shares of the company's stock valued at $221,163,000 after buying an additional 585,526 shares in the last quarter. Marshall Wace LLP raised its stake in Clorox by 549.8% in the fourth quarter. Marshall Wace LLP now owns 542,726 shares of the company's stock valued at $88,144,000 after buying an additional 459,203 shares during the last quarter. ExodusPoint Capital Management LP boosted its holdings in Clorox by 187.9% in the fourth quarter. ExodusPoint Capital Management LP now owns 698,900 shares of the company's stock worth $113,508,000 after acquiring an additional 456,114 shares in the last quarter. Finally, Amundi grew its stake in shares of Clorox by 42.6% during the fourth quarter. Amundi now owns 1,032,283 shares of the company's stock worth $165,816,000 after acquiring an additional 308,234 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company's stock.

Clorox Trading Down 1.2 %

Shares of CLX traded down $1.61 during midday trading on Thursday, reaching $137.50. The company had a trading volume of 1,221,111 shares, compared to its average volume of 1,303,239. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37. The firm has a 50 day simple moving average of $146.01 and a 200-day simple moving average of $155.99. The stock has a market cap of $16.94 billion, a PE ratio of 37.57, a price-to-earnings-growth ratio of 2.62 and a beta of 0.61.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period last year, the company posted $2.16 EPS. Research analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.55%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox's payout ratio is currently 133.33%.

Wall Street Analysts Forecast Growth

CLX has been the topic of several research reports. Citigroup reduced their price target on shares of Clorox from $165.00 to $150.00 and set a "neutral" rating for the company in a research report on Monday, April 14th. DA Davidson decreased their target price on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a research report on Wednesday, February 5th. Barclays cut their price target on Clorox from $139.00 to $134.00 and set an "underweight" rating on the stock in a research report on Friday, April 11th. Wells Fargo & Company lowered their target price on Clorox from $155.00 to $145.00 and set an "equal weight" rating on the stock in a research note on Wednesday, April 16th. Finally, StockNews.com lowered Clorox from a "buy" rating to a "hold" rating in a report on Sunday, January 5th. Three investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the stock. According to MarketBeat, Clorox has a consensus rating of "Hold" and an average price target of $153.83.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.